Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $406.96 | 20 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $95.87 | 5 | $0 (2024) |
| PFIZER INC. | $84.21 | 4 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $80.67 | 4 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $54.50 | 3 | $0 (2023) |
| Gilead Sciences, Inc. | $34.43 | 1 | $0 (2024) |
| Breas Medical, Inc. | $26.96 | 1 | $0 (2024) |
| Inari Medical, Inc. | $15.29 | 1 | $0 (2023) |
| Mallinckrodt Hospital Products Inc. | $15.03 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $120.08 | 5 | Gilead Sciences, Inc. ($34.43) |
| 2023 | $226.40 | 12 | Janssen Pharmaceuticals, Inc ($74.67) |
| 2022 | $60.48 | 3 | Novartis Pharmaceuticals Corporation ($36.72) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/14/2024 | Breas Medical, Inc. | Vivo 45 LS (Device) | Food and Beverage | In-kind items and services | $26.96 | General |
| Category: Respiratory | ||||||
| 09/30/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: CRITICAL CARE | ||||||
| 08/05/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $34.43 | General |
| 08/01/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/22/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/14/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/07/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/10/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: Rare Disease | ||||||
| 10/26/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/12/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/28/2023 | Inari Medical, Inc. | CT THROMBECTOMY SYSTEM KIT (Device), FLOWTRIEVER CATHETER, S | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: VTE | ||||||
| 09/18/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Rare Disease | ||||||
| 08/31/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/22/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/15/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Rare Disease | ||||||
| 04/27/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/12/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/19/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/05/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: Rare Disease | ||||||
| 09/19/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 285 | 421 | $134,331 | $31,593 |
| 2022 | 3 | 81 | 153 | $41,773 | $10,182 |
| 2021 | 2 | 28 | 56 | $12,446 | $3,618 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 96 | 198 | $48,312 | $11,928 | 24.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 62 | 63 | $22,806 | $5,418 | 23.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 27 | 59 | $20,768 | $5,378 | 25.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 28 | 28 | $19,208 | $3,581 | 18.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 27 | 28 | $12,992 | $2,789 | 21.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 33 | 33 | $8,085 | $2,020 | 25.0% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Facility | 2023 | 12 | 12 | $2,160 | $480.00 | 22.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 37 | 84 | $19,146 | $4,690 | 24.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 19 | 43 | $14,265 | $3,340 | 23.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 25 | 26 | $8,362 | $2,152 | 25.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 15 | 42 | $8,358 | $2,428 | 29.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 13 | 14 | $4,088 | $1,190 | 29.1% |
About Rachel Shepard
Rachel Shepard is a Hospitalist healthcare provider based in New Orleans, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/20/2018. The National Provider Identifier (NPI) number assigned to this provider is 1982108502.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Rachel Shepard has received a total of $406.96 in payments from pharmaceutical and medical device companies, with $120.08 received in 2024. These payments were reported across 20 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($406.96).
As a Medicare-enrolled provider, Shepard has provided services to 394 Medicare beneficiaries, totaling 630 services with total Medicare billing of $45,393. Data is available for 3 years (2021–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Hospitalist
- Other Specialties Student in an Organized Health Care Education/Training Program, Internal Medicine
- Location New Orleans, LA
- Active Since 03/20/2018
- Last Updated 07/15/2021
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1982108502
Products in Payments
- XARELTO (Drug) $95.87
- ELIQUIS (Drug) $84.21
- ULTOMIRIS (Biological) $80.67
- ENTRESTO (Drug) $54.50
- Vivo 45 LS (Device) $26.96
- CT THROMBECTOMY SYSTEM KIT (Device) $15.29
- TERLIVAZ (Drug) $15.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hospitalist Doctors in New Orleans
Marc Matrana, M.d, M.D
Hospitalist — Payments: $853,108
Shradha Ahuja, Md, MD
Hospitalist — Payments: $8,423
Dr. Brian Halbert, M.d, M.D
Hospitalist — Payments: $3,054
Jared Dendy, M.d, M.D
Hospitalist — Payments: $2,958
Hunter Hall
Hospitalist — Payments: $1,703
Kateryna Poole, Md, MD
Hospitalist — Payments: $1,288